Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:12 pm Sale | 13G | ONCTERNAL THERAPEUTICS INC ONCT | VANGUARD GROUP INC | 2,860,906 4.85% | -3,234 (-0.11%) | View |
| 2022-07-08 4:56 pm Sale | 13G | ONCTERNAL THERAPEUTICS INC ONCT | BlackRock Inc. BLK | 1,005,532 2% | -2,192,006 (-68.55%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | ONCTERNAL THERAPEUTICS INC ONCT | BlackRock Inc. BLK | 3,197,538 6.5% | 3,197,538 (New Position) | View |
| 2021-02-16 5:04 pm Sale | 13G | ONCTERNAL THERAPEUTICS INC ONCT | ARMISTICE CAPITAL LLC | 1,280,930 3% | -295,541 (-18.75%) | View |
| 2021-02-16 09:48 am Sale | 13G | ONCTERNAL THERAPEUTICS INC ONCT | CVI Investments Inc. | 0 0% | -2,500,000 (Position Closed) | View |
| 2020-12-18 4:05 pm Purchase | 13D | ONCTERNAL THERAPEUTICS INC ONCT | HYDE JOSEPH R III | 1,468,142 2.99% | 38,084 (+2.66%) | View |
| 2020-12-18 12:06 pm Purchase | 13G | ONCTERNAL THERAPEUTICS INC ONCT | CVI Investments Inc. | 2,500,000 6.4% | 2,500,000 (New Position) | View |
| 2020-07-23 4:36 pm Purchase | 13D | ONCTERNAL THERAPEUTICS INC ONCT | Shanghai Pharmaceuticals (HK) Investment Ltd | 4,069,089 19.9% | 4,069,089 (New Position) | View |
| 2020-05-29 5:06 pm Purchase | 13G | ONCTERNAL THERAPEUTICS INC ONCT | ARMISTICE CAPITAL LLC | 1,576,471 9.1% | 1,576,471 (New Position) | View |
| 2020-02-14 4:04 pm Unchanged | 13G | ONCTERNAL THERAPEUTICS INC ONCT | PERCEPTIVE ADVISORS LLC | 0 0% | 0 (Unchanged) | View |
| 2019-08-01 07:30 am Purchase | 13D | ONCTERNAL THERAPEUTICS INC ONCT | HYDE JOSEPH R III | 1,430,058 9% | 1,430,058 (New Position) | View |
| 2019-06-18 2:56 pm Purchase | 13D | ONCTERNAL THERAPEUTICS INC ONCT | Shanghai Pharmaceutical (USA) Inc. | 2,495,114 16.2% | 2,495,114 (New Position) | View |